Human CD20 Stable CT26.WT Cell Line
| Catalog Number |
CBCL-579 |
| Price |
Online Inquiry |
| Unit Quantity |
1x106 cells / 1.0 ml |
Introduction
CT26.WT cell line stable expressing exogenous human CD20 gene
Application
Drug screening and biological assays
Background
CD20 (MS4A1) is a glycosylated phosphoprotein mainly expressed on the cell surface of all B-cells beginning at the pro-B phase (CD45R+, CD117+) and progressively increasing in concentration until maturity. CD20 is a highly attractive target antigen of several approved monoclonal or bispecific antibodies, which are all active agents in the treatment of all B cell lymphomas, leukemias, and B cell-mediated autoimmune disease.
Product Information
| Category |
Immune Molecules Cell Lines |
| Cell Line Name |
Human CD20 Stable CT26.WT Cell Line |
| Pharmaceutical Target |
Immune Molecules |
| Species |
Mouse |
| Host Cell Line |
CT26 |
| Cell Type |
Mouse colon cancer cell line |
| Morphology |
Monolayer |
| Growth Properties |
Adherent |
| Selection Marker |
Puromycin |
| Seeding Density |
Thaw entire contents into an appropriate T25 flask. |
| Subculture Ratio |
Recommended a ratio of 1:4-1:10. |
| Recommended Medium |
RPMI1640 + 10% FBS + 10 μg/ml Puromycin |
| Storage Method |
Frozen in liquid nitrogen with 70% medium, 20% FBS and 10% DMSO |
| Stability |
Stable in culture over 10 passages |
| QC |
WB |
| Shipping |
Shipping in dry ice |
| Biosafety Level |
BSL-1 |
| Caution |
For Research Use Only |
For research use only. Not for any other purpose.
